|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 1/04 | (2006.01) |
| A61K 35/741 | (2015.01) | ||
| A61K 35/74 | (2015.01) | ||
| A61K 9/20 | (2006.01) | ||
| G01N 33/569 | (2006.01) | ||
| C12N 1/20 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/12 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3564357 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19176151.9 |
| Date of filing the European patent application | 2011-02-01 | |
| (97) | Date of publication of the European application | 2019-11-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
| (46) | Date of publication of the claims translation | 2022-07-11 |
| (30) | Number | Date | Country code |
| 33728310 P | 2010-02-01 | US | |
| 35118410 P | 2010-06-03 | US |
| (72) |
HLAVKA, Edwin J. , US
|
| (73) |
Ferring Microbiome Inc. ,
2660 Patton Road, Roseville, Minnesota 55113,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bakterioterapija, skirta Clostridium difficile sukeltam kolitui |
| BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS |
| Payment date | Validity (years) | Amount | |
| 2026-01-19 | 16 | 347.00 EUR |
| 2027-02-01 |